Company: IXHL
Filing Date: 2025-04-17
Form Type: PRER14A
Source: 0001213900-25-033013
Chunk: 34

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-17
Form: PRER14A
Chunk 34
---
 VOTE SUCH SHARES ON PROPOSAL NO. 1 SHALL BE CONFERRED BY SUCH PROXY; PROVIDED, FURTHER, THAT IF A STOCKHOLDER HAS SHARES OF COMMON STOCK THAT ARE SUBJECT TO THE VOTING RESTRICTION AND ARE NOT ENTITLED TO VOTE ON THIS PROPOSAL 1 AND SUCH STOCKHOLDER DOES NOT SPECIFY ON ITS PROXY CARD OR VOTING INSTRUCTION FORM HOW SUCH STOCKHOLDER’S SHARES ARE TO BE VOTED ON THIS PROPOSAL NO. 1, ANY SHARES THAT ARE NOT SUBJECT TO THE VOTING RESTRICTION AND ARE ENTITLED TO VOTE ON PROPOSAL NO 1 WILL BE VOTED IN FAVOR OF THIS PROPOSAL NO 1, AND ANY SHARES THAT ARE SUBJECT TO THE VOTING RESTRICTION AND ARE NOT ENTITLED TO VOTE ON PROPOSAL NO. 1 WILL NOT BE VOTED ON THIS PROPOSAL NO. 1.

<div align='center'>17

Proposal No. 2
APPROVAL OF THE CHARTER AMENDMENT PROPOSAL</div>

Our board of directors has determined that it
is advisable to increase the number of shares of our common stock authorized for issuance under our Amended and Restated Certificate of
Incorporation from 100,000,000 shares to 800,000,000 shares, and has voted to recommend that the stockholders adopt an amendment to our
Amended and Restated Certificate of Incorporation effecting the proposed increase. The full text of the Certificate of Amendment to the
Amended and Restated Certificate of Incorporation is attached to this proxy statement as . If our stockholders approve
the proposal, subject to the discretion of the board of directors, we will file the Certificate of Amendment to our Amended and Restated
Certificate of Incorporation with the Secretary of State of the State of Delaware as soon as practicable.

As of April 21, 2025, of our 100,000,000 authorized
shares, 27,546,753 shares of our common stock were issued and outstanding, an additional approximately 6,238,112 shares were reserved
for issuance under our various stock-based plans and awards granted thereunder or upon the exercise of outstanding options and warrants
(other than the Warrants issued in the Private Placement), seven shares of our common stock are reserved for issuance under our April 7, 2025 at-the-market offering Sales Agreement with A.G.P./